# Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

> **NCT01519063** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 75 (actual)

## Conditions studied

- Alcohol Drinking

## Interventions

- **DRUG:** Naltrexone and memantine first
- **DRUG:** Naltrexone and Placebo first

## Key facts

- **NCT ID:** NCT01519063
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2017-03-29
- **Final completion:** 2017-05-01
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2020-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519063, "Naltrexone and Memantine Effects on Alcohol Drinking Behaviors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01519063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*